Clinical Trial Update: MT10109L in the Treatment of Glabellar Lines (GL) With or Without Concurrent Treatment of Lateral Canthal Lines (LCL) [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating MT10109L for glabellar lines with or without concurrent treatment of lateral canthal lines has completed and results were posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Glabellar Lines
• Lateral Canthal Lines

Drugs mentioned

• MT10109L

Snippet

Sponsor: Medy-Tox | Conditions: Glabellar Lines, Lateral Canthal Lines | Phase 3 | Status: COMPLETED | Results posted: 2023-04-21